Amneal Pharmaceuticals (AMRX) Receivables - Net (2017 - 2026)
Amneal Pharmaceuticals' Receivables - Net was $1.02 billion in Q2 2026, up 26.1% from $809.23 million a year earlier and up 19.9% from the prior quarter.
Powered by 
Analysis
Amneal Pharmaceuticals (AMRX) Receivables - Net (2017 - 2026) Analysis & Trends
At the end of FY2025, Receivables - Net at Amneal Pharmaceuticals came in at $895.61 million, up 15.4% from FY2024.
- Receivables - Net shows a five-year compound annual growth rate of 7.0% (FY2020 to FY2025).
- In earlier years, Receivables - Net was $776.22 million in FY2024 (+26.3%), $614.69 million in FY2023 (-17.1%), $741.79 million in FY2022 (+12.0%) and $662.58 million in FY2021 (+3.7%).
- The Q2 2026 figure marks the highest quarterly Receivables - Net in data going back to Q4 2017.
- Compared with a year earlier, Receivables - Net has increased for ten straight quarters, with growth averaging 15.5% over the last eight quarters.
- The best year-over-year quarter for Receivables - Net over five years was Q4 2024 (growth of 26.3%); the worst was Q4 2023 (a decline of 17.1%).
- Per Business Quant data, AMRX's Receivables - Net in the three quarters before Q2 2026 was $851.37 million (Q1 2026), $895.61 million (Q4 2025) and $886.49 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,156.90 Bn | 1,125.48 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 623.56 Bn | 542.09 Bn | 17.26 Bn |
| 3 | AbbVie | 511.45 Bn | 484.57 Bn | 12.70 Bn |
| 4 | Merck | 365.96 Bn | 320.33 Bn | 12.21 Bn |
| 5 | Novartis Ag | 297.17 Bn | 261.16 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.14 Bn | 234.83 Bn | 12.86 Bn |
| 7 | Amgen | 234.28 Bn | 189.68 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 193.09 Bn | 167.28 Bn | 6.22 Bn |
| 9 | Pfizer | 171.61 Bn | 118.25 Bn | 10.94 Bn |
| 10 | Amneal Pharmaceuticals | 6.25 Bn | 5.44 Bn | 334.51 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.02 Bn |
| Mar 31, 2026 | 851.37 Mn |
| Dec 31, 2025 | 895.61 Mn |
| Sep 30, 2025 | 886.49 Mn |
| Jun 30, 2025 | 809.23 Mn |
| Mar 31, 2025 | 754.72 Mn |
| Dec 31, 2024 | 776.22 Mn |
| Sep 30, 2024 | 756.63 Mn |
| Jun 30, 2024 | 778.64 Mn |
| Mar 31, 2024 | 668.96 Mn |
| Dec 31, 2023 | 614.69 Mn |
| Sep 30, 2023 | 692.55 Mn |
| Jun 30, 2023 | 674.89 Mn |
| Mar 31, 2023 | 545.76 Mn |
| Dec 31, 2022 | 741.79 Mn |
| Sep 30, 2022 | 628.74 Mn |
| Jun 30, 2022 | 688.85 Mn |
| Mar 31, 2022 | 538.31 Mn |
| Dec 31, 2021 | 662.58 Mn |
| Sep 30, 2021 | 627.95 Mn |
API Access
Amneal Pharmaceuticals Receivables - Net API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-net&ticker=AMRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-net", "ticker": "AMRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-net&ticker=AMRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();